ArticleWorld journal of urology2026
The simple stone score as a predictor of stone-free status following pediatric percutaneous nephrolithotomy.
Article in World journal of urology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purposeTo evaluate the predictive performance of the Simple Stone Score (SSS) in pediatric percutaneous nephrolithotomy (PCNL) and compare it with the Stone-Kidney Size (SKS) score, developed specifically for this population.
methodsData from 145 consecutive pediatric patients who underwent PCNL between January 2008 and January 2024 were retrospectively analyzed. The SSS, based on largest stone diameter (LSD) and calyceal stone distribution (CSD), was applied. LSD was categorized as < 30 mm, 30–40 mm, or > 40 mm. CSD was classified as Grade I (single calyx or renal pelvis), Grade II (extension into one additional calyx), or Grade III (more than two calyces or complete staghorn stones). Residual fragments < 4 mm were considered clinically insignificant (CIRFs), and both stone-free and CIRF cases were defined as treatment success. The predictive performance of SSS for post-PCNL stone-free status was evaluated.
resultsThe overall stone-free rate (SFR) was 68.3%, which increased to 74.5% when CIRFs were considered. On multivariate analysis, prior open stone surgery (p = 0.019), previous PCNL (p = 0.001), stone location (p = 0.011), and SSS (p = 0.008) were identified as independent predictors of SFR. Regarding treatment success, previous PCNL (p = 0.004), stone location (p = 0.020), and SSS (p = 0.003) remained significant independent predictors. Receiver operating characteristic curve analysis demonstrated no significant difference between the predictive performance of the SSS and SKS systems. However, decision curve analysis indicated that the SSS model offered a more consistent net clinical benefit.
conclusionThis study shows that the SSS is a reliable tool for predicting stone-free status in pediatric PCNL patients, comparable to the SKS and validated for this population.
Indexed as
Identifiers
41697373What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.